Director, Global HEOR

Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

Summary

The purpose of this job is to develop Global HEOR strategies for the assigned Specialty products and execute global, comprehensive and scientifically rigorous HEOR activities for the assigned products, aligned with the global R&D, commercial and market access strategies, contributing to optimal pricing, reimbursement and market access.

Responsibilities

• Provision of HEOR strategic direction to project teams
  Provide HEOR strategic direction to Global Project Teams (GPTs) and Global Brand Teams (GBTs) and provide recommendations on such aspects as appropriate comparators, target patient populations, clinical and economic end-points and patient-reported outcomes (PROs), ensuring the payer perspective is incorporated in the assigned clinical development programs and the evidence needed to support optimal market access is addressed. Contribute HEOR sections to target product profiles (TPPs), product development plans, clinical development plans, and commercialization plans and other critical documents.
  • Level: Contribute to multiple Ph1-2b or single Ph3 GPTs and GBTs independently and with consultation if needed.
• Development of value propositions and execution and reporting of HEOR studies
  Lead the development of global value propositions that differentiate the assigned products for health policy decision-makers, government & commercial payers, consumers and other stakeholders and identify the supporting evidence requirements, aligned with the GPTs, GBTs, Regional HEOR and Market Access functions.
  Plan and conduct HEOR studies such as early economic models, burden of illness studies and the development and validation of patient-reported outcome (PRO) instruments and lead the preparation of global value dossiers which present the product value propositions and the supporting evidence, aligned with the product development strategies and endorsed by the GPTs, GBTs, Regional HEOR and market access, to realize an optimal value demonstration of the products.
  • Level: Develop value propositions, identify evidence requirements and plan and execute HEOR studies independently, and with consultation if needed.
• HEOR scientific publications & communications
  Develop HEOR communications (e.g. manuscripts, scientific forum presentations, slide kits, symposia), in collaboration with multi-functional teams, to build the peer reviewed published evidence supporting the value propositions for assigned products.
  • Level: Develop independently and with consultation if needed.
• Vendor management
  Effectively manage the entire process for projects outsourced to external consultancies and contractors, ensuring delivery according to key milestones, budget and to agreed and expected quality.
  • Level: Manage
• Internal Collaboration
  Collaborate and communicate effectively with internal global/ regional functional peers and cross functional colleagues/ teams, share knowledge and provide input on global HEOR needs, to enhance effective functioning of the DS matrix structure as well as contributing to meet program objectives and global HEOR goals.
  • Level: Contribute to matrix teams independently and with consultation if needed.
• External Collaboration
  Lead and/or contribute to Daiichi Sankyo meetings with external bodies such as regulatory and health technology assessment agencies to seek external input on HEOR evidence generation strategies and plans for assigned products.
  Effectively represent Daiichi Sankyo at major external agency meetings, public health policy and reimbursement discussion forums with decision makers from these constituencies and partner with key opinion leaders (KOLs), ensuring the desired positioning of DS is articulated and taken into account.
  • Level: Contribute to meetings with external regulatory and HTA bodies independently and with consultation if needed.
• Knowledge of HEOR scientific methods and health policy environment
  Maintain and continue to enhance knowledge about HEOR methods and the evolving public health policy and reimbursement environment in major (USA, Europe and Japan) and other pertinent markets.

Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education Qualifications (from an accredited college or university)

• Master's Degree in a relevant discipline (e.g., health economics, health services research, medicine, pharmacy, public health, psychometrics, epidemiology, and decision sciences) required
  PhD in a relevant discipline (e.g., health economics, health services research, medicine, pharmacy, public health, psychometrics, epidemiology, and decision sciences) preferred

Experience Qualifications

• 10 or More Years experience in the healthcare or pharmaceutical industry or commensurate education/experience, 8 of which must be working in the health economics and outcomes research field preferred
• Hands on experience with HEOR methodologies across all phases of the product life cycle preferred
• Keen insight and track record of successful application of HEOR data with key external stakeholders in all major international markets preferred
• Knowledge of Specialty therapy areas preferred

Travel
Ability to travel up to 10%

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.